Ebola virus: from discovery to vaccine

被引：230

作者：

Feldmann, H ^{[1
]}

Jones, S

Klenk, HD

Schnittler, HJ

机构：

[1] Univ Manitoba, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada

[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada

[3] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada

[4] Univ Marburg, Inst Virol, D-35032 Marburg, Germany

[5] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol, Dresden, Germany

来源：

NATURE REVIEWS IMMUNOLOGY | 2003年 / 3卷 / 08期

基金：

加拿大健康研究院;

关键词：

D O I：

10.1038/nri1154

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre- and post-exposure interventions makes the development of rapid diagnostics, new antiviral agents and protective vaccines a priority for many nations. Further insight into the ecology, immunology and pathogenesis of Ebola virus will promote the delivery of these urgently required tools.

引用

页码：677 / 685

页数：9

共 91 条

[1] C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans
Alvarez, CP
Lasala, F
Carrillo, J
Muñiz, O
Corbí, AL
Delgado, R
[J]. JOURNAL OF VIROLOGY, 2002, 76 (13) : 6841 - 6844
[2] Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
Baize, S
Leroy, EM
Georges-Courbot, MC
Capron, M
Lansoud-Soukate, J
Debré, P
Fisher-Hoch, SP
McCormick, JB
McCormick, JB
Georges, AJ
[J]. NATURE MEDICINE, 1999, 5 (04) : 423 - 426
[3] Inflammatory responses in Ebola virus-infected patients
Baize, S
Leroy, EM
Georges, AJ
Georges-Courbot, MC
Capron, M
Bedjabaga, I
Lansoud-Soukate, J
Mavoungou, E
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) : 163 - 168
[4] ULTRASTRUCTURAL PATHOLOGY OF EXPERIMENTAL EBOLA HEMORRHAGIC-FEVER VIRUS-INFECTION
BASKERVILLE, A
FISHERHOCH, SP
NEILD, GH
DOWSETT, AB
[J]. JOURNAL OF PATHOLOGY, 1985, 147 (03) : 199 - 209
[5] The Ebola virus VP35 protein functions as a type IIFN antagonist
Basler, CF
Wang, XY
Mühlberger, E
Volchkov, V
Paragas, J
Klenk, HD
Garcia-Sastre, A
Palese, P
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12289 - 12294
[6] THE ASIALOGLYCOPROTEIN RECEPTOR IS A POTENTIAL LIVER-SPECIFIC RECEPTOR FOR MARBURG VIRUS
BECKER, S
SPIESS, M
KLENK, HD
[J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 393 - 399
[7] Hemorrhagic fever viruses as biological weapons - Medical and public health management
Borio, L
Inglesby, T
Peters, CJ
Schmaljohn, AL
Hughes, JM
Jahrling, PB
Ksiazek, T
Johnson, KM
Meyerhoff, A
O'Toole, T
Ascher, MS
Bartlett, J
Breman, JG
Eitzen, EM
Hamburg, M
Hauer, J
Henderson, A
Johnson, RT
Kwik, G
Layton, M
Lillibridge, S
Nabel, GJ
Osterholm, MT
Perl, TM
Russell, P
Tonat, K
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18): : 2391 - 2405
[8] EBOLA HEMORRHAGIC-FEVER - EXPERIMENTAL-INFECTION OF MONKEYS
BOWEN, ETW
PLATT, GS
SIMPSON, DIH
MCARDELL, LB
RAYMOND, RT
[J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1978, 72 (02) : 188 - 191
[9] A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever
Bray, M
Davis, K
Geisbert, T
Schmaljohn, C
Huggins, J
[J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) : 651 - 661
[10] Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus
Bray, M
Hatfill, S
Hensley, L
Huggins, JW
[J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2001, 125 (04) : 243 - 253

← 1 2 3 4 5 6 7 8 9 10 →